🚨 Characteristics, aetiology and outcomes in patients with and without HCC 🚨 Insights from 🏴‍☠️ @AdrianStanleyGI in @FrontGastro_BMJ — 🔹 21.6% of HCC patients had no cirrhosis - diagnosed older & with more advanced disease. 🔹 No survival difference between cirrhotic & non-cirrhotic patients, but TACE outcomes were better for non-cirrhotic. Full paper here – fg.bmj.com/content/15/5/380 #HCC #Cirrhosis #LiverCancer #MedicalResearch #CancerCare #Hepatology @BASLedu @BritSocGastro @EASLnews @EASLedu @AASLDtweets @PhilSmithIsBack @dr_aditi_kumar @OTavabie @DrJMKennedy @DunnePdj @TrevorTabone @eathar_s @IrenePerezMD @KGananandan @zare_benjamin @medicalreg @dtleiberman

After a sensational first round the #FGcup, "Colonic stents" have cinched it! Congratulations - in the quarter finals due to happen in a week or so! Look out for next voting tomorrow and it's a biggie - Hepatology go head to head with ERCP for a spot in the quarter finals! Don't miss it! @sheiybani @DunnePdj @DrJMKennedy @OTavabie @dr_aditi_kumar @PhilSmithIsBack

The next paper in the running of #FGCup is "Colonic stents: who, when, where" bit.ly/3PccHqx Even if you don't do these yourself, the article sets out every simply who you would request and when. If you are time-limited and wondering about whether your patient might be a candidate, there is a great flow-chart that can act as a helpful decision-aid (prior to the MDT of course!). @ttham1 @sheiybani @OTavabie @dr_aditi_kumar @VivekGoodoory @DrJMKennedy @DunnePdj @RexWHHui